Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Devices-for-cloaking-transplanted-cells

 Method for treating Parkinson's disease employing an ATP-sensitive potassium channel blocker
What is claimed is: 1. A method for treating Parkinson's disease, which comprises administering ...


 Method of treatment of parkinson's disease
We claim: 1. A method of treatment of Parkinson's disease in a patient in need of such treatment, ...


 4-aminoethoxy indolone derivatives
What is claimed is: 1. A compound of the formula I: ##STR5## in which: Y is hydrogen, halogen or ...


 Genetically engineered cells that produce produce L. Dopa
In one aspect, the present invention provides a process of increasing the production of dopamine in ...


 C. elegans deletion mutants
What is claimed is: 1. A nematode having null mutations in hop-1 and sel-12, said nematode having a ...


 Feline hepatocyte growth factor
The invention claimed is: 1. An isolated DNA or RNA encoding a protein having an amino acid ...


 ppRB.sup.110 -phosphoprotein the retinoblastoma susceptibility gene product
OF FIGURES FIG. 1 is the chromatogram illustrating the identification of RB proteins by ...


 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
It has now been discovered that tumor formation in a patient can be treated or prevented by ...


 Mutants of the RB and P53 genes
OF THE INVENTION Definitions The term "functional expression of the gene" meant to include the ...


 Oncolytic virus therapy
OF THE INVENTION As used herein the term "human cells" means cells isolated from a human, or ...


 Devices for cloaking transplanted cells

Details
Inventors: Lanza, Robert P.; Chick, William;
Assignee: Biohybrid Technologies LLC (Shrewsbury, MA)
Primary Examiner: Jones; Dwayne C.
Assistant Examiner: Delacroix-Muirheid; C.
Attorney, Agent or Firm:

Implantable devices that include a source of a therapeutic substance and a capture agent are disclosed.

DETAILED DESCRIPTION A variety of devices can be used to contain or cloak a source of a therapeutic substance, often cells, which source provides the substance to a host or recipient subject.
Such devices include implantable devices, of both the diffusion and perfusion types, and extra corporeal devices, e.
g.
, those through which blood of the host or recipient is passed.
In such devices, host molecules can attack the source of the therapeutic substance and impair the function of the device.
Semipermiable components are used to inhibit the ability of host molecules to enter the device and attack the source of therapeutic substance.
The inventors have discovered that release, by the device, of components of the source of therapeutic substance, can stimulate a host response against the device and that capture of such components, prior to release or prior to becoming available to the immune system of the host, can improve the performance of the device, e.
g.
, by extending its useful lifetime.
The inventors have discovered that the inclusion in an implantable device of a capture agent, e.
g.
, an antibody directed against an antigen of the source of a therapeutic substance, which sequesters therapeutic source molecules, can improve the performance of the device, e.
g.
, by extending its useful lifetime.
Accordingly, the invention features, an implantable device which includes a source of a therapeutic substance, e.
g.
, an islet, and a capture agent, e.
g.
, an antibody which binds a component of the therapeutic substance, disposed within or on a semipermeable component.
The capture agents are preferably immobilized within the interior of the device or on its surface or are in a different compartment than the source of a therapeutic substance, or otherwise immobilized to keep it from contacting the source of a therapeutic substance.
The capture agent can, e.
g.
, coupled to a substrate, e.
g.
, an inert bead in a compartment of the microreactor, or can be coupled to the surface of the microreactor, or to the surface of a component of the microreactor



Related patents
  Terminally-branched polymeric linkers and polymeric conjugates containing the same
In one aspect of the invention, compounds of Formula (I) are provided: ##STR6## wherein: J is ##STR7## E.sub.1-4 are independently selected from the group consisting of ...
  Rectally absorbable form of L-dopa
What is claimed is: 1. A method of enhancing the rate of absorption of a rectally administered composition comprising rectally administering to a patient a ...
  Rectally absorbable form of L-dopa
What is claimed is: 1. A method of enhancing the rate of absorption of a rectally administered composition comprising a therapeutically effective dosage amount of an ...
  Rectally absorbable form of L-dopa
What is claimed is: 1. A pharmaceutical composition for enhancing rectal absorption of L-dopa by administering a formulation comprising a therapeutically effective ...
  Method to treat Parkinsons disease
I claim: 1. The method of treatment of Parkinson's disease and related neurological syndromes which consists of administering by the oral or sublingual route to a ...
  Method of using cytoprotective alcohols to treat neural disease and neural injury
The present invention is grounded in the surprising discovery that hexacosanol and analogues and homologs thereof, including saturated and unsaturated straight chain ...
  Methods of treating Parkinson's disease using melanin
OF THE INVENTION One aspect of the present invention relates to the treatment of a mammal having a disease of a tissue which exhibits a melanin deficiency by the ...
  Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds
OF THE INVENTION The present invention thus provides as a novel compound the R(+)-enantiomer of N-propargyl-1-aminoindan [R(+)PAI] of the formula (I): ##STR1## and ...
  L-DOPA ethyl ester to treat Parkinson's disease
OF THE INVENTION This invention provides a composition which comprises a pharmaceutically acceptable carrier and an active ingredient, such active ingredient comprising ...
  Episomal vector systems and related methods
The present invention provides papilloma virus episomal vector systems and methods for papilloma virus episomal vector replication in a variety of human and animal cells ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved